Russell Investments Group, Ltd. Novartis Ag Transaction History

Russell Investments Group, Ltd.

  • $84.2 Billion
  • Q3 2025

A detailed history of Russell Investments Group, Ltd. transactions in Novartis Ag stock. As of the latest transaction made, Russell Investments Group, Ltd. holds 72,604 shares of NVS stock, worth $9.55 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
72,604
Previous 22,893 217.14%
Holding current value
$9.55 Million
Previous $2.77 Million 236.1%
% of portfolio
0.01%
Previous 0.0%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 13, 2025
BUY
$113.5 - $129.73 $5.64 Million - $6.45 Million
49,711 Added 217.14%
72,604 $9.31 Million
Q2 2025

Aug 13, 2025
BUY
$101.96 - $121.01 $596,058 - $707,424
5,846 Added 34.29%
22,893 $2.77 Million
Q1 2025

May 13, 2025
BUY
$97.14 - $115.57 $677,745 - $806,331
6,977 Added 69.29%
17,047 $1.9 Million
Q4 2024

Feb 13, 2025
BUY
$96.78 - $117.18 $62,423 - $75,581
645 Added 6.84%
10,070 $979,000
Q3 2024

Nov 13, 2024
BUY
$106.13 - $120.89 $323,696 - $368,714
3,050 Added 47.84%
9,425 $1.08 Million
Q2 2024

Aug 08, 2024
BUY
$92.57 - $107.37 $174,309 - $202,177
1,883 Added 41.92%
6,375 $678,000
Q1 2024

May 08, 2024
BUY
$95.27 - $108.47 $95,651 - $108,903
1,004 Added 28.78%
4,492 $434,000
Q4 2023

Feb 05, 2024
BUY
$92.27 - $101.54 $86,087 - $94,736
933 Added 36.52%
3,488 $352,000
Q3 2023

Nov 13, 2023
SELL
$94.73 - $105.13 $2.73 Million - $3.03 Million
-28,818 Reduced 91.86%
2,555 $260,000
Q2 2023

Aug 10, 2023
SELL
$92.52 - $104.91 $1.66 Million - $1.88 Million
-17,893 Reduced 36.32%
31,373 $3.17 Million
Q1 2023

May 09, 2023
SELL
$80.03 - $92.81 $4.44 Million - $5.15 Million
-55,484 Reduced 52.97%
49,266 $4.53 Million
Q4 2022

Feb 08, 2023
BUY
$75.55 - $92.52 $6.01 Million - $7.36 Million
79,517 Added 315.13%
104,750 $9.5 Million
Q3 2022

Nov 04, 2022
SELL
$74.61 - $87.26 $10.8 Million - $12.6 Million
-144,725 Reduced 85.15%
25,233 $1.92 Million
Q2 2022

Jul 29, 2022
BUY
$80.52 - $93.75 $6.62 Million - $7.7 Million
82,167 Added 93.59%
169,958 $14.4 Million
Q1 2022

May 05, 2022
SELL
$80.11 - $90.62 $227,832 - $257,723
-2,844 Reduced 3.14%
87,791 $7.7 Million
Q4 2021

Jan 21, 2022
BUY
$79.7 - $88.13 $141,467 - $156,430
1,775 Added 2.0%
90,635 $7.93 Million
Q3 2021

Nov 08, 2021
SELL
$81.78 - $95.14 $255,235 - $296,931
-3,121 Reduced 3.39%
88,860 $7.27 Million
Q2 2021

Aug 04, 2021
BUY
$85.24 - $94.15 $7.84 Million - $8.66 Million
91,981 New
91,981 $8.39 Million
Q4 2020

Feb 08, 2021
SELL
$78.07 - $94.43 $2.05 Million - $2.48 Million
-26,299 Closed
0 $0
Q3 2020

Nov 09, 2020
SELL
$82.14 - $91.0 $8,788 - $9,737
-107 Reduced 0.41%
26,299 $2.29 Million
Q2 2020

Aug 05, 2020
SELL
$80.93 - $91.1 $2.35 Million - $2.65 Million
-29,057 Reduced 52.39%
26,406 $2.31 Million
Q1 2020

May 06, 2020
SELL
$70.67 - $99.01 $552,074 - $773,466
-7,812 Reduced 12.35%
55,463 $4.57 Million
Q4 2019

Jan 29, 2020
BUY
$84.35 - $95.37 $632,034 - $714,607
7,493 Added 13.43%
63,275 $5.99 Million
Q3 2019

Nov 01, 2019
SELL
$85.54 - $94.26 $2.56 Million - $2.82 Million
-29,970 Reduced 34.95%
55,782 $4.85 Million
Q2 2019

Aug 09, 2019
BUY
$75.4 - $92.8 $165,880 - $204,160
2,200 Added 2.63%
85,752 $7.82 Million
Q1 2019

May 13, 2019
BUY
$75.32 - $86.15 $1.68 Million - $1.92 Million
22,341 Added 36.5%
83,552 $8.02 Million
Q4 2018

Feb 11, 2019
BUY
$73.66 - $82.02 $7,218 - $8,037
98 Added 0.16%
61,211 $5.24 Million
Q3 2018

Oct 26, 2018
BUY
$66.94 - $77.43 $4.09 Million - $4.73 Million
61,113 New
61,113 $5.27 Million
Q4 2017

Feb 06, 2018
SELL
$72.33 - $77.64 $12 Million - $12.9 Million
-165,800 Closed
0 $0
Q3 2017

Nov 07, 2017
BUY
$74.14 - $77.27 $12.3 Million - $12.8 Million
165,800
165,800 $14.2 Million

Others Institutions Holding NVS

# of Institutions
1,599
Shares Held
137M
Call Options Held
1.53M
Put Options Held
2.22M
View Full List

About NOVARTIS AG

NVS Quotes by TradingView
  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $283B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Russell Investments Group, Ltd. Portfolio

Follow Russell Investments Group, Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Russell Investments Group, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Russell Investments Group, Ltd. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email